IPO market

Unlisted Ideas

Invest in Pre-IPO shares

IPO Ideas

Invest in IPO in just 3 clicks

About Us

Mahamaya Lifesciences IPO subscription

FPSMEBSEListed

Listed at

116

+0.00%

Mahamaya Lifesciences IPO is a SME fixed price IPO. Issue size is 70.44 Cr. Price band is ₹108 to ₹114 per share. Minimum investment is ₹2.78 L. Lot size is 1200 shares. Open from 11 Nov 2025 to 13 Nov 2025. Allotment on 14 Nov 2025. Listing on 18 Nov 2025 at BSE. Managed by Oneview Corporate Advisors Pvt.Ltd. Registrar: Kfin Technologies Limited. Key details for GMP, subscription, price, allotment, and listing in one place.

Live IPO subscription for Mahamaya Lifesciences IPO across categories. Total demand ₹70.24 L vs offered ₹41.17 L.

Official documents: RHP and DRHP.

Follow the latest IPO & unlisted research on iOS and Android.

Google Play App Store

Mahamaya Lifesciences IPO subscription

FPSMEBSEListed

Listed at

116

+0.00%

Live IPO subscription for Mahamaya Lifesciences IPO across categories. Total demand ₹70.24 L vs offered ₹41.17 L.

Official documents: RHP and DRHP.

Subscription Status

Category	Offered	Placed	Times
QII	11,76,000	14,01,600	1.19
NII	8,82,000	35,14,800	3.99
NII (>10L)	5,88,000	32,50,800	5.53
NII (<10L)	2,94,000	2,64,000	0.90
Retail	20,59,200	21,07,200	1.02
Total	70,23,600	41,17,200	1.71

Application Wise Subscription

Category	Offered	Placed	Times
HNI (>10L)	161	85	0.53
HNI (3-10L)	81	74	0.91
Retail	858	878	1.02
Total	1,037	1,100	0.94

Mahamaya Lifesciences IPO subscription FAQs

How to read QIB / NII / Retail demand and what it implies.

What is the Mahamaya Lifesciences IPO subscription status?

The Mahamaya Lifesciences IPO subscription status shows how many times the issue has been subscribed across different investor categories such as QIB, NII (HNI), and Retail. It reflects the demand for the IPO during the subscription period.

Where can I check live Mahamaya Lifesciences IPO subscription numbers?

You can check live Mahamaya Lifesciences IPO subscription data on this page, which is updated based on official exchange data released during the IPO subscription period.

What are the investor categories in Mahamaya Lifesciences IPO subscription?

The Mahamaya Lifesciences IPO subscription is divided into the following categories: Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII / HNI), and Retail Individual Investors (RII). Each category has a separate quota and subscription data.

What does QIB subscription mean in Mahamaya Lifesciences IPO?

QIB subscription in Mahamaya Lifesciences IPO indicates the demand from institutional investors such as mutual funds, banks, and insurance companies.

What does NII or HNI subscription mean in Mahamaya Lifesciences IPO?

NII (also known as HNI) subscription in Mahamaya Lifesciences IPO represents bids from high-net-worth investors who apply for shares above the retail limit.

What does Retail subscription mean in Mahamaya Lifesciences IPO?

Retail subscription in Mahamaya Lifesciences IPO shows demand from individual investors who apply within the retail investment limit specified in the IPO details.

How often is Mahamaya Lifesciences IPO subscription data updated?

Mahamaya Lifesciences IPO subscription data is updated multiple times during market hours based on information published by stock exchanges.

Does higher Mahamaya Lifesciences IPO subscription guarantee allotment?

No, higher Mahamaya Lifesciences IPO subscription does not guarantee allotment. In case of oversubscription, allotment is done through a lottery system as per SEBI guidelines.

Is Mahamaya Lifesciences IPO subscription data official?

Yes, the subscription data shown for Mahamaya Lifesciences IPO is based on official data released by stock exchanges, but it may change during the day.

How does Mahamaya Lifesciences IPO subscription impact listing?

IPO subscription indicates demand, but the actual listing performance depends on market conditions, company fundamentals, and investor sentiment at the time of listing.